EUVIMEDEUVIMED entdecken
Crossref

METTL1‐Mediated m7G Modification of GINS2 mRNA Activates STAT3 to Drive Esophageal Squamous Cell Carcinoma Progression

Wu Han iD, Zhimin Shen, Peipei Zhang iD

Journal of Gastroenterology and Hepatology · 2026-11 · 41 (11) · 3482-3497

DOI: 10.1111/jgh.70777 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 28.09.2026. Verfasst von Wu Han und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Esophageal Neoplasms, Chromosomal Proteins, Non-Histone, RNA, Messenger. Die Arbeit nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

METTL1‐mediated m7G modification plays a procancer role in various malignant tumors, but whether it promotes the progression of esophageal squamous cell carcinoma (ESCC) by regulating the DNA replication factor GINS2 and tumor‐associated macrophage polarization remains unclear.

Methods

The expression and function of GINS2 were examined through in vitro and in vivo experiments. RIP, MeRIP, and RNA stability assays were used to validate the regulatory effect of METTL1 on GINS2 modification. The impact on macrophage polarization was explored using a coculture system and STAT3 agonist Colivelin rescue experiments.

Results

GINS2 was highly expressed in ESCC. Knockdown of GINS2 inhibited the malignant phenotypes of tumor cells and reversed epithelial–mesenchymal transition (EMT). Mechanistically, METTL1 enhanced the stability of GINS2 mRNA through m7G modification, thereby activating the STAT3 pathway and inducing M2 polarization of macrophages. The STAT3 agonist Colivelin partially reversed the tumor‐suppressive effects induced by GINS2 knockdown. In vivo knockdown of GINS2 suppressed tumor growth and M2 infiltration.

Conclusion

METTL1‐mediated m7G modification stabilizes GINS2 mRNA, activates the STAT3 pathway, induces M2 polarization, and promotes ESCC progression. This axis provides a novel potential diagnostic and therapeutic target for ESCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

STAT3 Transcription FactorEsophageal NeoplasmsChromosomal Proteins, Non-HistoneRNA, MessengerEsophageal Squamous Cell CarcinomaMethyltransferasesHumansDisease ProgressionEpithelial-Mesenchymal TransitionAnimalsRNA StabilitySignal TransductionRNA MethylationCell Line, TumorTumor-Associated Macrophages

Stichwörter der Autor:innen

GINS2METTL1STAT3 signaling pathwayesophageal squamous cell carcinomam7G modificationmacrophage M2 polarizationtumor immune microenvironment

Substanzen

STAT3 Transcription FactorChromosomal Proteins, Non-HistoneRNA, MessengerMethyltransferasesSTAT3 protein, human

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.

ORCID-Profile: Wu Han, Peipei Zhang

Zitieren

APA

Han, W., Shen, Z., & Zhang, P. (2026). METTL1‐Mediated m7G Modification of GINS2 mRNA Activates STAT3 to Drive Esophageal Squamous Cell Carcinoma Progression. Journal of Gastroenterology and Hepatology, 41(11), 3482-3497. https://doi.org/10.1111/jgh.70777

Vancouver

Han W, Shen Z, Zhang P. METTL1‐Mediated m7G Modification of GINS2 mRNA Activates STAT3 to Drive Esophageal Squamous Cell Carcinoma Progression. Journal of Gastroenterology and Hepatology. 2026;41(11):3482-3497. doi:10.1111/jgh.70777

BibTeX
@article{Han2026,
  author = {Han, Wu and Shen, Zhimin and Zhang, Peipei},
  title = {METTL1‐Mediated m7G Modification of GINS2 mRNA Activates STAT3 to Drive Esophageal Squamous Cell Carcinoma Progression},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2026},
  volume = {41},
  number = {11},
  pages = {3482--3497},
  doi = {10.1111/jgh.70777}
}
Kostenlos starten →